Finding a better drug for epilepsy: Antiinflammatory targets

Stefanie Dedeurwaerdere, Alon Friedman, Paolo F. Fabene, Andrèy Mazarati, Yoshiya L. Murashima, Annamaria Vezzani, Tallie Z. Baram

Research output: Contribution to journalArticle

Abstract

This monograph summarizes one of the sessions of the XI Workshop on Neurobiology of Epilepsy (WONOEP), and provides a critical review of the current state of the field. Speakers and discussants focused on several broad topics: (1) the coexistence of inflammatory processes encompassing several distinct signal-transduction pathways with the epileptogenic process; (2) evidence for the contribution of specific inflammatory molecules and processes to the onset and progression of epilepsy, as well as to epilepsy-related morbidities including depression; (3) the complexity and intricate cross-talk of the pathways involved in inflammation, and the discrete, often opposite roles of a given mediator in neurons versus other cell types. These complexities highlight the challenges confronting the field as it aims to define inflammatory molecules as promising targets for epilepsy prevention and treatment.

Original languageEnglish
Pages (from-to)1113-1118
Number of pages6
JournalEpilepsia
Volume53
Issue number7
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Epilepsy
Anti-Inflammatory Agents
Pharmaceutical Preparations
Neurobiology
Signal Transduction
Inflammation
Morbidity
Education
Neurons

Keywords

  • Brain inflammation
  • Disease-modifying
  • Epilepsy
  • Epileptogenesis
  • Therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Dedeurwaerdere, S., Friedman, A., Fabene, P. F., Mazarati, A., Murashima, Y. L., Vezzani, A., & Baram, T. Z. (2012). Finding a better drug for epilepsy: Antiinflammatory targets. Epilepsia, 53(7), 1113-1118. https://doi.org/10.1111/j.1528-1167.2012.03520.x

Finding a better drug for epilepsy : Antiinflammatory targets. / Dedeurwaerdere, Stefanie; Friedman, Alon; Fabene, Paolo F.; Mazarati, Andrèy; Murashima, Yoshiya L.; Vezzani, Annamaria; Baram, Tallie Z.

In: Epilepsia, Vol. 53, No. 7, 07.2012, p. 1113-1118.

Research output: Contribution to journalArticle

Dedeurwaerdere, S, Friedman, A, Fabene, PF, Mazarati, A, Murashima, YL, Vezzani, A & Baram, TZ 2012, 'Finding a better drug for epilepsy: Antiinflammatory targets', Epilepsia, vol. 53, no. 7, pp. 1113-1118. https://doi.org/10.1111/j.1528-1167.2012.03520.x
Dedeurwaerdere S, Friedman A, Fabene PF, Mazarati A, Murashima YL, Vezzani A et al. Finding a better drug for epilepsy: Antiinflammatory targets. Epilepsia. 2012 Jul;53(7):1113-1118. https://doi.org/10.1111/j.1528-1167.2012.03520.x
Dedeurwaerdere, Stefanie ; Friedman, Alon ; Fabene, Paolo F. ; Mazarati, Andrèy ; Murashima, Yoshiya L. ; Vezzani, Annamaria ; Baram, Tallie Z. / Finding a better drug for epilepsy : Antiinflammatory targets. In: Epilepsia. 2012 ; Vol. 53, No. 7. pp. 1113-1118.
@article{0ded13afcd0a42fa9a11a5c59798d574,
title = "Finding a better drug for epilepsy: Antiinflammatory targets",
abstract = "This monograph summarizes one of the sessions of the XI Workshop on Neurobiology of Epilepsy (WONOEP), and provides a critical review of the current state of the field. Speakers and discussants focused on several broad topics: (1) the coexistence of inflammatory processes encompassing several distinct signal-transduction pathways with the epileptogenic process; (2) evidence for the contribution of specific inflammatory molecules and processes to the onset and progression of epilepsy, as well as to epilepsy-related morbidities including depression; (3) the complexity and intricate cross-talk of the pathways involved in inflammation, and the discrete, often opposite roles of a given mediator in neurons versus other cell types. These complexities highlight the challenges confronting the field as it aims to define inflammatory molecules as promising targets for epilepsy prevention and treatment.",
keywords = "Brain inflammation, Disease-modifying, Epilepsy, Epileptogenesis, Therapy",
author = "Stefanie Dedeurwaerdere and Alon Friedman and Fabene, {Paolo F.} and Andr{\`e}y Mazarati and Murashima, {Yoshiya L.} and Annamaria Vezzani and Baram, {Tallie Z.}",
year = "2012",
month = "7",
doi = "10.1111/j.1528-1167.2012.03520.x",
language = "English",
volume = "53",
pages = "1113--1118",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "7",

}

TY - JOUR

T1 - Finding a better drug for epilepsy

T2 - Antiinflammatory targets

AU - Dedeurwaerdere, Stefanie

AU - Friedman, Alon

AU - Fabene, Paolo F.

AU - Mazarati, Andrèy

AU - Murashima, Yoshiya L.

AU - Vezzani, Annamaria

AU - Baram, Tallie Z.

PY - 2012/7

Y1 - 2012/7

N2 - This monograph summarizes one of the sessions of the XI Workshop on Neurobiology of Epilepsy (WONOEP), and provides a critical review of the current state of the field. Speakers and discussants focused on several broad topics: (1) the coexistence of inflammatory processes encompassing several distinct signal-transduction pathways with the epileptogenic process; (2) evidence for the contribution of specific inflammatory molecules and processes to the onset and progression of epilepsy, as well as to epilepsy-related morbidities including depression; (3) the complexity and intricate cross-talk of the pathways involved in inflammation, and the discrete, often opposite roles of a given mediator in neurons versus other cell types. These complexities highlight the challenges confronting the field as it aims to define inflammatory molecules as promising targets for epilepsy prevention and treatment.

AB - This monograph summarizes one of the sessions of the XI Workshop on Neurobiology of Epilepsy (WONOEP), and provides a critical review of the current state of the field. Speakers and discussants focused on several broad topics: (1) the coexistence of inflammatory processes encompassing several distinct signal-transduction pathways with the epileptogenic process; (2) evidence for the contribution of specific inflammatory molecules and processes to the onset and progression of epilepsy, as well as to epilepsy-related morbidities including depression; (3) the complexity and intricate cross-talk of the pathways involved in inflammation, and the discrete, often opposite roles of a given mediator in neurons versus other cell types. These complexities highlight the challenges confronting the field as it aims to define inflammatory molecules as promising targets for epilepsy prevention and treatment.

KW - Brain inflammation

KW - Disease-modifying

KW - Epilepsy

KW - Epileptogenesis

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84863717234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863717234&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1167.2012.03520.x

DO - 10.1111/j.1528-1167.2012.03520.x

M3 - Article

C2 - 22691043

AN - SCOPUS:84863717234

VL - 53

SP - 1113

EP - 1118

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 7

ER -